Elicio Therapeutics Inc. (ELTX)
NASDAQ: ELTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 8, 10:03 AM ET
ELTX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $46.39M
- EPS (TTM)
- -$2.16
- Dividend yield
- None
- 52-week range
- 1.71 – 16.00
- Day range
- 1.75 – 1.85
- Volume / Avg
- 27.25K / 352.93K
- Beta
- —
- Shares outstanding
- 26.28M
52-week range
ELTX stock today
Shares of Elicio Therapeutics (ELTX) are trading lower on Oct 8 at $1.77, a drop of 4.59% or $0.085 per share, versus the S&P 500's 0.26% decline. Shares are 89.0% below their 52-week high of $16.00, set on Jun 10, 2026 and 3.5% above the 52-week low of $1.71, near the bottom of the past year's range. ELTX is down 76.8% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 82.9%.
Elicio Therapeutics has posted a net loss over the last twelve months (EPS of -$2.16), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Elicio Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2021
Elicio Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| DWTXDogwood Therapeutics Inc. | 1.45 | +1.40% | $49.29M | vs ELTX |
| ANVSAnnovis Bio Inc. | 1.15 | -4.94% | $49.08M | vs ELTX |
| CRVOCervoMed Inc. | 3.21 | +0.94% | $48.53M | vs ELTX |
| CELUCelularity Inc. Class A | 1.49 | +1.02% | $48.19M | vs ELTX |
| SERSerina Therapeutics Inc. | 2.02 | +0.23% | $51.31M | vs ELTX |
| HYPDHyperion DeFi Inc. | 3.39 | -5.61% | $51.53M | vs ELTX |
| EDSAEdesa Biotech Inc. | 3.89 | +0.13% | $52.56M | vs ELTX |
| ZYBTZhengye Biotechnology Holding Limited Class A | 1.13 | -2.59% | $53.55M | vs ELTX |
Indexes, lists and sector
Elicio Therapeutics stock FAQ
What is Elicio Therapeutics's stock price today?
ELTX last traded at $1.77 as of Oct 8, 10:03 AM EDT, down 4.59% on the day. Prices are delayed at least 15 minutes.
Does Elicio Therapeutics pay a dividend?
No. Elicio Therapeutics does not currently pay a regular cash dividend.
Has ELTX ever split its stock?
Yes. The most recent ELTX stock split was a 1-for-10 split on Jun 2, 2023.
What is the ELTX 52-week high?
The 52-week high for ELTX is $16.00 and the 52-week low is $1.71. The stock is currently 89.0% below its high.